Home/Filings/4/0001209191-17-006520
4//SEC Filing

Versartis, Inc. 4

Accession 0001209191-17-006520

CIK 0001513818operating

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 8:32 PM ET

Size

7.3 KB

Accession

0001209191-17-006520

Insider Transaction Report

Form 4
Period: 2017-01-27
Hislop Colin
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2017-01-27+19,50024,500 total
  • Award

    Stock Option (Right to Buy)

    2017-01-27+43,70043,700 total
    Exercise: $14.30Exp: 2027-01-26Common Stock (43,700 underlying)
Footnotes (2)
  • [F1]Represents the grant of Restricted Stock Units that vest as follows: 25% of the shares subject to the award vest on each of the first, second, third and fourth anniversaries of the date of grant, respectively, subject to the officer's continuous service on each applicable vesting date.
  • [F2]3/48th of the shares subject to the option will become exercisable on 4/27/17 and 1/48th of the shares subject to the option will become exercisable monthly thereafter.

Issuer

Versartis, Inc.

CIK 0001513818

Entity typeoperating
IncorporatedTX

Related Parties

1
  • filerCIK 0001513818

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 8:32 PM ET
Size
7.3 KB